Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer

Qianping Li, Weijie Ma, Tianhong Li

Research output: Contribution to journal › Review article

Original languageEnglish (US)
Pages (from-to)S3186-S3191
JournalJournal of Thoracic Disease
Volume10
DOIs
StatePublished - Sep 1 2018

Fingerprint

Non-Small Cell Lung Carcinoma
Membranes
sortilin

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer. / Li, Qianping; Ma, Weijie; Li, Tianhong.

In: Journal of Thoracic Disease, Vol. 10, 01.09.2018, p. S3186-S3191.

Research output: Contribution to journal › Review article

Li, Q, Ma, W & Li, T 2018, 'Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer', Journal of Thoracic Disease, vol. 10, pp. S3186-S3191. https://doi.org/10.21037/jtd.2018.08.25
Li Q, Ma W, Li T. Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer. Journal of Thoracic Disease. 2018 Sep 1;10:S3186-S3191. https://doi.org/10.21037/jtd.2018.08.25
Li, Qianping ; Ma, Weijie ; Li, Tianhong. / Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer. In: Journal of Thoracic Disease. 2018 ; Vol. 10. pp. S3186-S3191.
@article{fbc564e6a241448d9a30c1021c944d14,
title = "Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer",
author = "Qianping Li and Weijie Ma and Tianhong Li",
year = "2018",
month = "9",
day = "1",
doi = "10.21037/jtd.2018.08.25",
language = "English (US)",
volume = "10",
pages = "S3186--S3191",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",

}

TY - JOUR

T1 - Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer

AU - Li, Qianping

AU - Ma, Weijie

AU - Li, Tianhong

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85053798582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053798582&partnerID=8YFLogxK

U2 - 10.21037/jtd.2018.08.25

DO - 10.21037/jtd.2018.08.25

M3 - Review article

AN - SCOPUS:85053798582

VL - 10

SP - S3186-S3191

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

ER -

Access to Document